FIELD: medicine.
SUBSTANCE: invention relates to application of Acizol, namely bis(1-vinylimidazole) zinc diacetate as coronary active anti-ischemia and anti-arrhythmia agent. Acizol makes it possible to limit development of necrosis zone in acute myocardium ischemia, to reduce frequency of complications and fatal cases, to normalize antrioventricular and intraventricular electrical conductivity , to prevent ciliary arrythmia.
EFFECT: improved anti-ischemia and anti-arrhythmia agent.
15 tbl, 7 dwg, 6 ex
Title | Year | Author | Number |
---|---|---|---|
HYPOLIPIDEMIC AND ANTIISHEMIC AGENT "SERPYSTEN" | 2007 |
|
RU2337701C1 |
ADAPTOGEN | 2004 |
|
RU2279877C2 |
ANTI-ISHEMIC AND ANTIHYPOXIC AGENT | 2007 |
|
RU2356573C1 |
ENCAPSULATED FORM OF ACYZOL | 2005 |
|
RU2290928C1 |
USING ACIZOL AS HEPATOPROTECTING AGENT | 2004 |
|
RU2260427C1 |
REMEDY FOR POISONING AND ITS COMPLICATIONS TREATMENT | 2006 |
|
RU2331417C1 |
SOLUTION FOR MAKING INJECTIONS | 2004 |
|
RU2276978C2 |
METHOD OF TREATING ISCHEMIC HEART DISEASE | 1996 |
|
RU2127117C1 |
METHOD OF PREVENTING CHRONIC TOXIC ARTERIAL HYPERTENSION AND CARDIOPATHY IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2363454C1 |
METHOD FOR TREATING PATIENTS FOR PERIODONTIUM DISEASES | 2005 |
|
RU2301062C2 |
Authors
Dates
2007-01-10—Published
2005-06-21—Filed